DK138691C - - Google Patents
Info
- Publication number
- DK138691C DK138691C DK525172A DK525172A DK138691C DK 138691 C DK138691 C DK 138691C DK 525172 A DK525172 A DK 525172A DK 525172 A DK525172 A DK 525172A DK 138691 C DK138691 C DK 138691C
- Authority
- DK
- Denmark
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5375071A GB1400999A (en) | 1971-11-19 | 1971-11-19 | Imidazo-triazine compounds and their use in therapeutic compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK138691B DK138691B (en) | 1978-10-16 |
| DK138691C true DK138691C (en) | 1979-03-26 |
Family
ID=10468856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK525172AA DK138691B (en) | 1971-11-19 | 1972-10-23 | Analogous process for the preparation of imidazo (5,1-f) triazinones or their salts. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US3840537A (en) |
| JP (1) | JPS563873B2 (en) |
| AT (1) | AT321923B (en) |
| AU (1) | AU472127B2 (en) |
| BE (1) | BE791025A (en) |
| CA (1) | CA990292A (en) |
| CH (1) | CH594671A5 (en) |
| DE (1) | DE2255172A1 (en) |
| DK (1) | DK138691B (en) |
| ES (1) | ES408736A1 (en) |
| FR (1) | FR2160407B1 (en) |
| GB (1) | GB1400999A (en) |
| IE (1) | IE37046B1 (en) |
| IL (1) | IL40686A (en) |
| NL (1) | NL7215646A (en) |
| PH (1) | PH9669A (en) |
| SE (1) | SE402915B (en) |
| ZA (1) | ZA727532B (en) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1457873A (en) * | 1973-01-04 | 1976-12-08 | Allen & Hanburys Ltd | Imidazotriazines |
| DE2314488C3 (en) * | 1973-03-23 | 1979-01-04 | C.H. Boehringer Sohn, 6507 Ingelheim | 8- (2,6-Dichlorophenyl) -7- (4-chlorophenyl) -5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazine, process for its preparation and medicament containing it |
| DE2335193A1 (en) * | 1973-07-11 | 1975-01-30 | Hoechst Ag | BIS-TRIAZINOBENZIMIDAZOLE AND THEIR PRODUCTION |
| US4115572A (en) * | 1977-02-03 | 1978-09-19 | American Cyanamid Company | Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma |
| US4107307A (en) * | 1977-02-03 | 1978-08-15 | American Cyanamid Company | Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones |
| USRE30511E (en) * | 1977-02-03 | 1981-02-10 | American Cyanamid Company | Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones |
| DK109578A (en) * | 1977-03-25 | 1978-09-26 | Allen & Hanburys Ltd | PROCEDURE FOR MAKING HETEROCYCLIC COMPOUNDS |
| US4107308A (en) * | 1977-10-18 | 1978-08-15 | American Cyanamid Company | Imidazo[1,5-d]-as-triazines |
| US4308384A (en) * | 1978-09-18 | 1981-12-29 | Glaxo Group Limited | Production of triazinones |
| HU187474B (en) * | 1981-11-18 | 1986-01-28 | Gyogyszerkutato Intezet,Hu | Process for producing new spiro-pyrazole-square bracket-1,5-d-square bracket closed-square bracket-1,2,4-square bracket closed-triazine derivatives |
| US4395547A (en) * | 1982-02-10 | 1983-07-26 | American Cyanamid Co. | Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones |
| AU622330B2 (en) * | 1989-06-23 | 1992-04-02 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides |
| US6624181B1 (en) * | 1997-02-28 | 2003-09-23 | Altana Pharma Ag | Synergistic combination |
| DE59803108D1 (en) * | 1997-11-12 | 2002-03-21 | Bayer Ag | 2-PHENYL-SUBSTITUTED IMIDAZOTRIAZINONE AS PHOSPHODIESTERASE INHIBITORS |
| DE19827640A1 (en) * | 1998-06-20 | 1999-12-23 | Bayer Ag | New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction |
| EP1107747A4 (en) | 1998-08-26 | 2003-04-23 | Smithkline Beecham Corp | Therapies for treating pulmonary diseases |
| PT1212089E (en) * | 1999-08-21 | 2006-08-31 | Altana Pharma Ag | ROFLUMILAST AND SALMETEROL SYNERGY COMBINATION |
| BR0209541A (en) * | 2001-05-09 | 2004-04-20 | Bayer Healthcare Ag | Use of 2-phenyl-substituted imidazotriazinones |
| GB0113343D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel Heterocycles 2 |
| GB0113344D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel heterocycles 3 |
| DE10135815A1 (en) | 2001-07-23 | 2003-02-06 | Bayer Ag | Use of imidazo-triazinone derivative phosphodiesterase 5 inhibitors e.g. for treatment of cardiac insufficiency, psoriasis, diabetes, cancer, glaucoma, bladder disease, Parkinson's disease or pain |
| DE10232113A1 (en) | 2002-07-16 | 2004-01-29 | Bayer Ag | Medicinal products containing vardenafil hydrochloride trihydrate |
| US7462614B2 (en) * | 2003-04-01 | 2008-12-09 | Smithkline Beecham Corporation | Imidazotriazine compounds |
| PT1740591E (en) | 2004-04-02 | 2009-09-24 | Osi Pharm Inc | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| DE102005001989A1 (en) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenous formulations of PDE inhibitors |
| DE102005009241A1 (en) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Dosage forms with controlled bioavailability |
| DE102005009240A1 (en) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Dosage forms with improved pharmacokinetic properties |
| KR20080056250A (en) * | 2005-09-29 | 2008-06-20 | 바이엘 헬스케어 아게 | Pde inhibitors and combinations thereof for the treatment of urological disorders |
| SI1951724T1 (en) | 2005-11-17 | 2011-09-30 | Osi Pharmaceuticals Llc | FUSED BICYCLIC mTOR INHIBITORS |
| US20100184769A1 (en) * | 2007-06-13 | 2010-07-22 | Bayer Schering Pharma Aktiengesellschaft | Pde inhibitors for the treatment of hearing impairment |
| JP2012524119A (en) | 2009-04-20 | 2012-10-11 | オーエスアイ・ファーマシューティカルズ，エルエルシー | Preparation of C-pyrazine-methylamine |
| CN103374002B (en) * | 2012-04-19 | 2015-07-15 | 山东轩竹医药科技有限公司 | Phosphodiesterase-5 inhibitor |
| JP2018508555A (en) * | 2015-03-16 | 2018-03-29 | 大日本住友製薬株式会社 | Bicyclic imidazolo derivatives |
| WO2017000276A1 (en) * | 2015-07-01 | 2017-01-05 | Merck Sharp & Dohme Corp. | Bicyclic heterocyclic compounds as pde2 inhibitors |
| WO2017204316A1 (en) * | 2016-05-27 | 2017-11-30 | 塩野義製薬株式会社 | 5-oxo-1,2,4-triazine derivative, and pharmaceutical composition thereof |
-
0
- BE BE791025D patent/BE791025A/en unknown
-
1971
- 1971-11-19 GB GB5375071A patent/GB1400999A/en not_active Expired
-
1972
- 1972-10-23 DK DK525172AA patent/DK138691B/en unknown
- 1972-10-23 IE IE1433/72A patent/IE37046B1/en unknown
- 1972-10-23 ZA ZA727532A patent/ZA727532B/en unknown
- 1972-10-25 US US00300749A patent/US3840537A/en not_active Expired - Lifetime
- 1972-10-26 AU AU48191/72A patent/AU472127B2/en not_active Expired
- 1972-10-27 IL IL40686A patent/IL40686A/en unknown
- 1972-11-01 CA CA155,720A patent/CA990292A/en not_active Expired
- 1972-11-06 SE SE7214358A patent/SE402915B/en unknown
- 1972-11-08 FR FR7239498A patent/FR2160407B1/fr not_active Expired
- 1972-11-10 DE DE2255172A patent/DE2255172A1/en not_active Withdrawn
- 1972-11-16 PH PH14090*UA patent/PH9669A/en unknown
- 1972-11-16 CH CH1668372A patent/CH594671A5/xx not_active IP Right Cessation
- 1972-11-17 ES ES408736A patent/ES408736A1/en not_active Expired
- 1972-11-17 JP JP11549572A patent/JPS563873B2/ja not_active Expired
- 1972-11-17 NL NL7215646A patent/NL7215646A/xx not_active Application Discontinuation
- 1972-11-17 AT AT982372A patent/AT321923B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE402915B (en) | 1978-07-24 |
| FR2160407A1 (en) | 1973-06-29 |
| IL40686A (en) | 1975-12-31 |
| CA990292A (en) | 1976-06-01 |
| IE37046B1 (en) | 1977-04-27 |
| AT321923B (en) | 1975-04-25 |
| IE37046L (en) | 1973-05-19 |
| FR2160407B1 (en) | 1975-10-17 |
| JPS563873B2 (en) | 1981-01-27 |
| BE791025A (en) | 1973-05-07 |
| AU4819172A (en) | 1974-05-16 |
| GB1400999A (en) | 1975-07-16 |
| ES408736A1 (en) | 1976-03-01 |
| PH9669A (en) | 1976-02-10 |
| JPS4857993A (en) | 1973-08-14 |
| AU472127B2 (en) | 1976-05-20 |
| ZA727532B (en) | 1973-07-25 |
| DK138691B (en) | 1978-10-16 |
| CH594671A5 (en) | 1978-01-13 |
| IL40686A0 (en) | 1972-12-29 |
| NL7215646A (en) | 1973-05-22 |
| US3840537A (en) | 1974-10-08 |
| DE2255172A1 (en) | 1973-05-24 |